Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451525 · ClinicalTrials.gov registry record
REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
A clinical trial, sponsored by Microvention-Terumo.
- Completed
- Registry status
- 710
- Enrollment target
NCT04451525 is a clinical trial that has completed, run by Microvention-Terumo. The registered enrollment target is 710 participants.
The verdict
NCT04451525 has completed, sponsored by Microvention-Terumo.
- COMPLETED
- Registry status
- 710 participants
- Enrollment target
Study Summary
To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.
Interventions
- DEVICE MicroVention Mechanical Thrombectomy Devices as first-line treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2025-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04451525
The ClinicalTrials.gov registry entry for NCT04451525 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 710 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Microvention-Terumo, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MicroVention Mechanical Thrombectomy Devices as first-line treatment is the first listed.
NCT04451525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04451525 about?
NCT04451525 is a clinical study titled "REal-World Analyses of Stroke - Thrombus Occlusion REtrieval". To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.
What is the current status of trial NCT04451525?
This trial is currently completed. The enrollment target is 710 participants. The study started on 2020-07-15. Estimated completion is 2025-06-09.
What interventions are being tested in trial NCT04451525?
The interventions under investigation include: MicroVention Mechanical Thrombectomy Devices as first-line treatment (DEVICE).
Who is sponsoring clinical trial NCT04451525?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.